Introduction {#Sec1}
============

Non-Hodgkin lymphomas (NHL) represent a heterogeneous group of cancers arising from lymphocytes for which the etiology remains largely unclear. While the major known risk factor for developing NHL is severe immunodeficiency \[[@CR1]\], the increased NHL risk among those with a family history of hematopoietic disease \[[@CR2]--[@CR5]\] suggests an important role for genetic susceptibility in NHL etiology. Investigations of germline genetic variation in large epidemiologic case--control studies have identified potentially relevant loci that may play a role in modulating risk for NHL \[[@CR6], [@CR7]\].

A recent pooled analysis of three large population-based NHL case--control studies that included the present study found a significant association between a polymorphism in the *IRF4* gene, rs12211228 and NHL risk \[[@CR8]\]. The *IRF4* gene (also known as *MUM1*) encodes a protein that is a member of the interferon regulatory factor family \[[@CR9]--[@CR12]\]. IRF4 is a B-cell proliferation and differentiation protein essential for class switch recognition and antibody maturation \[[@CR13], [@CR14]\] and is often found abnormally expressed in B cell lymphomas \[[@CR15]\]. In addition to serving as a marker for lymphoid tumors such as NHL, IRF4 has also been reported to act as a potential marker for melanoma \[[@CR16]\].

A recent large genome-wide association study demonstrated a convincing association between a different polymorphism of the *IRF4* gene, rs12203592, and pigmentation phenotypes, most notably hair color \[[@CR17]\]. This *IRF4* SNP was also shown to be associated with skin color, eye color, and a measure of skin tanning response to sunlight. This report was the first to suggest a link between a particular *IRF4* locus and human pigmentation, though the mechanism for the involvement of this immune regulatory gene in determining hair color and other pigmentation phenotypes remains unclear.

Interestingly, sun sensitivity and sun exposure have previously been linked with NHL. Hartge et al. \[[@CR18]\] previously showed a gradient of decreasing NHL risk with increasingly light eye color, one pigmentation phenotype believed to act as a marker of increased sun sensitivity. This relationship between risk for NHL and sun sensitivity and exposure is further supported by recent work from the International Lymphoma Epidemiology Consortium (InterLymph)\[[@CR19]\], where a pooled analysis of ten case--control studies of NHL showed a significant decrease in NHL risk with increasing recreational sun exposure.

In order to clarify the roles of these two *IRF4* polymorphisms and sun sensitivity in mediating NHL risk and to determine if their respective associations with NHL are confounded or modified by each other, we used a large US multi-center case--control study of NHL to evaluate the relationship between *IRF4* polymorphisms and markers of sun sensitivity and sun exposure and their roles in determining risk for non-Hodgkin lymphoma.

Materials and methods {#Sec2}
=====================

Study population {#Sec3}
----------------

The study population has been described previously in detail \[[@CR3]\]. Briefly, we included 1,321 newly diagnosed non-Hodgkin lymphoma cases identified in four Surveillance, Epidemiology, and End Results (SEER) registries (Iowa; Detroit, MI; Los Angeles, CA; and Seattle, WA) between 1 July 1998 and 30 June 2000. Subjects were between the ages of 20 and 74 and had no evidence of HIV infection. A total of 1,057 population controls were identified by random digit dialing (under 65 years old) and from Medicare eligibility files (65 years and older). Overall participation rates were 76% in cases and 52% in controls; overall response rates were 59 and 44%, respectively. Written informed consent was obtained from each participant before interview. This study was approved by the institutional review boards at the NIH and at each participating SEER site (Iowa, Detroit, LA, and Seattle).

All study participants were asked to provide a venous blood or mouthwash buccal cell sample. We obtained blood samples from 1,172 (89%) cases (773 blood, 399 buccal) and 982 (93%) controls (668 blood, 314 buccal). Genotype frequencies were equivalent for individuals who provided blood compared with buccal cells.

Histopathology {#Sec4}
--------------

Each SEER registry provided non-Hodgkin lymphoma pathology and subtype information derived from abstracted reports by the local diagnosing pathologist. All cases were histologically confirmed and coded according to the *International Classification of Diseases for Oncology*, *2nd Edition* (ICD-O-2) \[[@CR20]\] and updated to the World Health Organization classification/ICD-O-3 \[[@CR21]\].

Questionnaire data {#Sec5}
------------------

The study used a split-sample design to investigate multiple etiologic risk factors in detail without overburdening the participants. A core set of questions was given to all respondents, and the remainder of questions were given to participants in either Group A (all African-American participants and 50% of non-African-American participants) or Group B (50% of non-African-American participants). Prior to the in-person interview, participants were mailed a form for listing residential and job history and either a family and medical history questionnaire (Group A) or a diet and lifestyle questionnaire (Group B). During the home visit, a trained interviewer administered a computer-assisted personal interview (CAPI) that included core questions on demographics, height and weight, occupational history, pesticide exposure, hair color, and hair dye use. The Group A CAPI also included an extended medical history and use of illicit drugs, while the Group B CAPI included an abbreviated medical history, cell phone use, allergies, hobbies, eye color, skin complexion, and sun sensitivity/exposure.

*Sun sensitivity and exposure*. During the interview, we asked participants to estimate how many hours they spent in the sun during the summer in the middle of the day (10:00 AM--4:00 PM). We asked separately for weekdays and weekend days and separately for specific periods of their lives including teenage years, twenties, thirties, and the most recent decade. In the analysis, we estimated typical weekly exposure to strong sunlight as a weighted average of weekend and weekday values. We also asked about the use of sun lamps or tanning booths, the typical number of months per year they had a tan, pigmentation characteristics including eye color and skin complexion, and some common measures of skin response to sunlight, including sun rashes and typical reaction to first hour of sun with no tan and no sunburn.

DNA extraction and genotyping {#Sec6}
-----------------------------

Study participants who did not provide a biologic specimen, did not have sufficient material for DNA extraction or sufficient DNA for genotyping, or whose genotyped sex was discordant from the questionnaire data were excluded from this analysis. As previously described \[[@CR22]\], DNA was extracted from blood clots or buffy coats (BBI Biotech, Gaithersburg, MD) using Puregene Autopure DNA extraction kits (Gentra Systems, Minneapolis, MN). DNA was extracted from buccal cell samples by phenol--chloroform extraction methods \[[@CR23]\].

We selected 15 tag single nucleotide polymorphisms (SNPs) in the *IRF4* gene as previously described \[[@CR8]\]; these included the two *a priori* SNPs of interest---rs12211228 and rs12203592. Genotyping was conducted at the National Cancer Institute Core Genotyping Facility (Advanced Technology Center, Gaithersburg, MD) using a custom-designed GoldenGate assay (Illumina, [www.illumina.com](http://www.illumina.com)). Sequence data and assay conditions are provided at <http://snp500cancer.nci.nih.gov> \[[@CR24]\]. SNP completion rates were \>95% for the 15 *IRF4* SNPs. Forty replicate samples from two blood donors each and duplicate samples from 100 participants processed in an identical fashion were interspersed for all assays and blinded from the laboratory. The 15 *IRF4* SNPs were \>95% concordant in the quality control samples. We excluded samples with a low completion rate (\<90%; 11 cases, 6 controls). Hardy--Weinberg Equilibrium (HWE) was observed in the control group for all *IRF4* SNPs (assessed separately for non-Hispanic Caucasians and blacks).

The final analytic population consisted of 990 cases and 828 controls.

Statistical analysis {#Sec7}
--------------------

*IRF4 and NHL*. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) as an estimate of relative risk for non-Hodgkin lymphoma outcomes using dichotomous (overall NHL) and polytomous (NHL subtypes) unconditional logistic regression models with the homozygous wild-type genotype as the referent group. We conducted stratified analyses by age (\<60 and ≥60 years), sex (male and female), and race (non-Hispanic Caucasians and blacks). Finding no significant differences in the risk estimates by each of these three strata, we pooled the results and adjusted for the study design variables: age (\<50, 50--59, 60--69, 70+), sex, race/ethnicity (non-Hispanic Caucasian, black, other), and study site (Iowa, Los Angeles, Seattle, Detroit). We calculated the *p* for trend based on the three-level ordinal variable (0, 1, 2) of homozygote wild-type, heterozygote, and homozygote variant. In addition to the individual risk estimates for each genotype, we evaluated the dominant model with homozygote wild-type as the referent group for comparison with heterozygotes and homozygote variants combined.

*Sun sensitivity and NHL*. In order to assess the association between the ordinal pigmentation and sun exposure variables and NHL, we calculated the OR and 95% CI using dichotomous and polytomous unconditional logistic regression models for NHL overall and NHL subtypes, respectively. We also calculated the *p* for trend value for linear trend in regression based on the categorical variables (0, 1, 2, etc.) for each level of exposure (e.g., for eye color: dark brown (0), light brown \[[@CR1]\], hazel (2), blue (3), green/blue-green (4)). For eye and hair color, skin complexion, reaction to first sun of the season, and hours in the mid-day sun in the last 10 years, the category corresponding to the lowest level of sun sensitivity or exposure was used as the referent category. All analyses were conducted both crude and adjusted for the study design variables age, race/ethnicity, sex, and study site. We note that we also included adjustment for education as a surrogate for SES; though education was slightly associated with sunlight exposure, additional adjustment for education did not appreciably alter the risk estimates for NHL (\<10%) and we therefore retained the most parsimonious model in our final model which excluded education. Secondary analyses restricted to subjects with genotype data and non-Hispanic Caucasian subjects with genotype data were also performed to assess consistency across population subgroups (adjusted for age, sex, and study site).

*IRF4 and sun sensitivity*. Among controls, we used logistic regression adjusted for age, sex, and study site to model the association between pigmentation or sun exposure and *IRF4* genotypes. For each exposure category, the OR and 95% CI were calculated for the heterozygotes and homozygous variants using the wild-type homozygotes as the referent group. We also calculated the *p* for trend across the genotypes in each exposure category to assess likelihood of that exposure category with each additional minor allele. We also conducted this analysis restricted to non-Hispanic Caucasians in the control group due to known variation in eye color, hair color, and other phenotypic features across race groups.

*Joint effects of IRF4 and sun sensitivity*. For each sun sensitivity exposure, we calculated the OR and 95% CI for NHL using a common referent group and also stratified by *IRF4* genotype under the dominant model, combining heterozygotes and homozygous variants. We calculated the *p*-value for interaction for each exposure and *IRF4* SNP for NHL risk based on the scored variable for each risk factor and for the genotype. In these calculations, we scored the genotype using a two-level categorization to assess risk for the presence of a variant allele. Statistical significance for interaction was evaluated with the Wald test in models that included a product term for the scored risk factor and the scored genotype. The category corresponding to the lowest level of sun sensitivity or sun exposure was used as the referent group for each exposure. Analyses were conducted using SAS version 9.1 (SAS Institute, Cary, NC).

Results {#Sec8}
=======

Table [1](#Tab1){ref-type="table"} shows selected characteristics of the NCI-SEER study population. Briefly, the majority of cases and controls were non-Hispanic Caucasians, cases were slightly younger than controls, and there were slightly more men than women in both cases and controls. Cases and controls were distributed roughly evenly into interview groups A and B. The most common NHL subtypes were diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma.Table 1Characteristics of NCI-SEER case--control study participantsCharacteristicControlsNHL cases*n* (%)*n* (%)SEER registry    Detroit139 (17)197 (20)    Iowa246 (30)301 (30)    Los Angeles199 (24)234 (24)    Seattle244 (29)258 (26)Sex    Male443 (54)536 (54)    Female385 (47)454 (46)Age (years)    \<50203 (25)277 (28)    50--59177 (21)235 (24)    60--69285 (34)311 (31)    70+163 (20)167 (17)Race/Ethnicity    White, non-Hispanic646 (78)828 (84)    Black112 (14)64 (6)    Asian/other/unknown70 (8)98 (10)Education    \<12 years77 (9)98 (10)    12--15 years485 (59)611 (62)    16+ years266 (32)280 (28)NHL histology    DLBCL--294 (30)    Follicular lymphoma--246 (25)    Marginal zone lymphoma--82 (8)    CLL/SLL--101 (10)    Mantle cell lymphoma--40 (4)    Lymphoplasmacytic lymphoma--24 (2)    Burkitt lymphoma--11 (1)    Mycosis fungoides/Sézary syndrome--18 (2)    Peripheral T-cell lymphoma--41 (4)    NHL, not otherwise specified--133 (13)DNA source    Blood598 (72)688 (69)    Buccal230 (28)302 (31)Interview group    Group A\*461 (56)547 (55)    Group B\*\*367 (44)443 (45)Total participants828990*CLL*/*SLL* chronic lymphocytic leukemia/small lymphocytic lymphoma, *DLBCL* diffuse large B-cell lymphoma, *NCI* National Cancer Institute, *NHL* non-Hodgkin lymphoma, *SEER* surveillance, epidemiology, and end results\* Group A: extended medical history, use of illicit drugs, family medical history in addition to core questions\*\* Group B: abbreviated medical history, allergies, hobbies, sun exposure (including eye color and skin complexion), phone use, food frequency questionnaire in addition to core questions

*IRF4 and NHL*. Fifteen SNPs in the *IRF4* gene were evaluated for associations with non-Hodgkin lymphoma (Supplementary Table 1). We observed a significant decrease in risk for NHL with the *IRF4* SNP rs12211228 (OR~CG~ = 0.81, 95% CI = 0.65--1.00; OR~CC~ = 0.76, 95% CI = 0.35--1.65; *p*-trend = 0.04; Table [2](#Tab2){ref-type="table"}). Results were consistent when restricted to non-Hispanic Caucasian subjects. We observed no statistically significant association between the *IRF4* SNP rs12203592 and NHL (Table [2](#Tab2){ref-type="table"}). Further, no other *IRF4* SNPs showed a statistically significant association with overall NHL (Supplementary Table 1).Table 2Association between selected *IRF4* SNPs and overall risk for non-Hodgkin lymphoma*IRF4* SNPGenotypeAll subjectsNon-Hispanic Caucasian subjectsAll subjects in interview Group B^†^ControlsAll NHLOR (95% CI)\*ControlsAll NHLOR (95% CI)\*\*ControlsAll NHLOR (95% CI)\**n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)rs12203592CC605 (73)730 (74)1.00(Ref.)444 (69)588 (71)1.00(Ref.)252 (70)307 (71)1.00(Ref.)CT202 (24)239 (24)0.92(0.74, 1.15)182 (28)219 (27)0.90(0.72, 1.14)98 (27)115 (27)0.95(0.69, 1.31)TT18 (2)19 (2)0.81(0.42, 1.57)17 (3)19 (2)0.85(0.43, 1.67)8 (2)9 (2)0.96(0.36, 2.57)CT or TT220 (27)258 (26)0.91(0.74, 1.13)199 (31)238 (29)0.90(0.72, 1.13)106 (30)124 (29)0.95(0.69, 1.30)*p*-trend0.37640.35880.7572rs12211228GG576 (70)724 (73)1.00(Ref.)436 (68)588 (71)1.00(Ref.)258 (72)305 (71)1.00(Ref.)CG236 (29)253 (26)0.81(0.65, 1.00)196 (30)227 (27)0.85(0.68, 1.07)96 (27)122 (28)1.06(0.77, 1.46)CC14 (2)13 (1)0.76(0.35, 1.65)12 (2)13 (2)0.88(0.40, 1.98)6 (2)5 (1)0.81(0.24, 2.75)CG or CC250 (30)266 (27)0.80(0.65, 0.99)208 (32)240 (29)0.85(0.68, 1.07)102 (28)127 (29)1.05(0.76, 1.43)*p*-trend0.04320.19230.8636*CLL*/*SLL* chronic lymphocytic leukemia/small lymphocytic lymphoma, *CI* confidence interval, *DLBCL* diffuse large B-cell lymphoma, *OR* odds ratio, *NHL* non-Hodgkin lymphoma, *SNP* single nucleotide polymorphism\* Adjusted for age, race/ethnicity, sex, study site\*\* Adjusted for age, sex, study site^†^Group B participants have data on eye color, skin complexion, sun exposures, and diet

*Sun sensitivity and NHL*. Lighter eye and hair color were both statistically significantly associated with decreased NHL risk (Table [3](#Tab3){ref-type="table"}). The associations were more pronounced for eye color than hair color, and both associations were consistent in analyses restricted to participants with *IRF4* genotype data and/or subjects self-reported as non-Hispanic Caucasians. Hours in the mid-day sun in the last 10 years was also associated with decreased NHL risk. Other markers of coloring and sun exposure and sensitivity including skin complexion and reaction to first sun of the season were not associated with NHL risk.Table 3Association between pigmentation and sun exposures and overall risk for non-Hodgkin lymphomaExposureAll subjectsAll subjects with genotype dataNon-Hispanic Caucasians w/genotype dataControlsAll NHLOR (95% CI)\*ControlsAll NHLOR (95% CI)\*ControlsAll NHLOR (95% CI)\**n* (%)*n* (%)*n* (%)*n* (%)*n* (%)*n* (%)Eye color    Dark brown93 (20)158 (29)1.00(Ref.)73 (20)121 (28)1.00(Ref.)55 (17)96 (24)1.00(Ref.)    Light brown41 (9)50 (9)0.76(0.47, 1.25)32 (9)34 (8)0.65(0.37, 1.16)23 (7)30 (8)0.75(0.39, 1.45)    Hazel84 (18)96 (17)0.64(0.43, 0.96)71 (20)73 (17)0.61(0.39, 0.95)69 (21)69 (17)0.57(0.35, 0.92)    Blue180 (39)188 (34)0.60(0.42, 0.84)140 (39)155 (36)0.66(0.45, 0.98)138 (42)153 (39)0.65(0.43, 0.97)    Green/Blue-green64 (14)59 (11)0.49(0.31, 0.78)45 (12)49 (11)0.61(0.36, 1.02)43 (13)47 (12)0.59(0.34, 1.01)    *p*-trend0.00050.03780.0295Hair color    Black/dark brown462 (44)572 (43)1.00(Ref.)354 (43)401 (41)1.00(Ref.)198 (31)273 (33)1.00(Ref.)    Medium brown223 (21)317 (24)1.00(0.80, 1.25)177 (21)261 (26)1.13(0.87, 1.46)162 (25)239 (29)1.07(0.82, 1.41)    Light Brown/dark blonde239 (23)285 (22)0.81(0.65, 1.02)189 (23)214 (22)0.84(0.65, 1.09)182 (28)206 (25)0.81(0.61, 1.06)    Light blonde93 (9)86 (7)0.62(0.45, 0.87)75 (9)66 (7)0.65(0.45, 0.94)73 (11)64 (8)0.63(0.43, 0.93)    Red39 (4)58 (4)1.02(0.66, 1.57)33 (4)47 (5)1.05(0.65, 1.71)31 (5)46 (6)1.05(0.64, 1.73)    *p*-trend0.02940.08700.0640Skin complexion    Dark20 (4)30 (5)1.00(Ref.)18 (5)28 (6)1.00(Ref.)15 (5)23 (6)1.00(Ref.)    Medium252 (55)306 (56)0.77(0.42, 1.41)198 (55)232 (54)0.74(0.40, 1.40)174 (53)204 (52)0.77(0.38, 1.53)    Light189 (41)215 (39)0.69(0.37, 1.29)145 (40)172 (40)0.72(0.38, 1.39)139 (42)168 (43)0.74(0.37, 1.51)    *p*-trend0.23870.49040.5588Reaction to first sun of season    No change19 (4)22 (4)1.00(Ref.)17 (5)18 (4)1.00(Ref.)14 (4)16 (4)1.00(Ref.)    Tan w/o burn75 (16)88 (16)1.03(0.51, 2.06)64 (18)71 (17)1.10(0.52, 2.33)54 (17)59 (15)1.03(0.45, 2.33)    Mild burn to tan200 (44)245 (45)1.04(0.54, 2.00)152 (42)182 (42)1.16(0.57, 2.37)137 (42)168 (43)1.14(0.53, 2.44)    Burn w/o blisters131 (29)143 (26)0.90(0.46, 1.77)100 (28)118 (27)1.10(0.53, 2.29)96 (30)112 (28)1.01(0.46, 2.20)    Blistering burn34 (7)51 (9)1.32(0.61, 2.84)25 (7)41 (10)1.64(0.71, 3.81)24 (7)39 (10)1.52(0.62, 3.71)    *p*-trend0.84480.34680.4966Hours in mid-day sun (last 10 years)    \<7 h/week159 (35)216 (39)1.00(Ref.)120 (34)162 (38)1.00(Ref.)114 (35)147 (37)1.00(Ref.)    \<14 h/week126 (27)145 (26)0.84(0.61, 1.15)103 (29)115 (27)0.82(0.57, 1.17)93 (29)107 (27)0.89(0.61, 1.29)    \<28 h/week123 (27)131 (24)0.73(0.53, 1.02)93 (26)105 (24)0.80(0.55, 1.16)84 (26)94 (24)0.83(0.56, 1.23)    28+ h/week51 (11)59 (11)0.73(0.46, 1.15)42 (12)50 (12)0.77(0.47, 1.27)35 (11)47 (12)0.92(0.54, 1.58)    *p*-trend0.05790.19820.4924*CI* confidence interval, *IU* international unit, *NHL* non-Hodgkin lymphoma, *OR* odds ratio\* Adjusted for age, race/ethnicity, sex, and study site\*\* Adjusted for age, sex, and study site

*IRF4 and sun sensitivity*. Table [4](#Tab4){ref-type="table"} shows associations between the two *a priori IRF4* SNPs of interest (rs12203592 and rs12211228) and measures of sun sensitivity and sun exposure among non-Hispanic Caucasian population controls. Presence of the variant allele in the *IRF4* SNP rs12203592 was associated with eye color and hair color. The association between hair color and the *IRF4* rs12203592 SNP was most pronounced with increasingly light hair color. Compared to dark brown eyes, the magnitude of association was equivalent for all other eye colors which were strongly associated with the *IRF4* rs12203592 variant allele. Curiously, the association between *IRF4* rs12203592 with hair color and eye color appear to be in opposite directions; this is consistent with the original GWAS results from Han et al. \[[@CR17]\] though was not further explored.Table 4Association between pigmentation and sun exposures and selected *IRF4* SNPs among non-Hispanic Caucasian controls*IRF4*CCCTTTCT/TTChi square(rs12203592)*n* (%)*n* (%)OR (95% CI)\**n* (%)OR (95% CI)\**n* (%)OR (95% CI)\**p*Eye color    Dark brown49 (89)6 (11)1.00(Ref.)0 (0)----6 (11)1.00(Ref.)    Light brown16 (70)6 (26)4.46(1.05, 19.00)1 (4)----7 (30)5.17(1.25, 21.35)0.0569    Hazel41 (60)26 (38)4.71(1.69, 13.14)1 (1)----27 (40)4.85(1.75, 13.47)    Blue89 (65)43 (32)4.47(1.73, 11.57)4 (3)----47 (35)4.81(1.87, 12.36)    Green/blue-green29 (67)13 (30)4.68(1.29, 17.05)1 (2)----14 (33)4.92(1.36, 17.83)Hair color    Black/dark brown112 (57)77 (39)1.00(Ref.)8 (4)1.00(Ref.)85 (43)1.00(Ref.)    Medium brown107 (66)50 (31)0.63(0.40, 1.00)4 (2)0.53(0.15, 1.86)54 (34)0.62(0.40, 0.97)0.0002    Light brown/dark blonde141 (78)37 (20)0.35(0.22, 0.57)3 (2)0.27(0.07, 1.08)40 (22)0.35(0.22, 0.55)    Light blonde62 (85)10 (14)0.24(0.11, 0.50)1 (1)0.19(0.02, 1.57)11 (15)0.23(0.11, 0.47)    Red22 (71)8 (26)0.55(0.22, 1.35)1 (3)0.54(0.06, 4.83)9 (29)0.55(0.23, 1.30)Skin complexion    Dark14 (93)1 (7)1.00(Ref.)0 (0)----1 (7)1.00(Ref.)    Medium122 (70)49 (28)5.47(0.66, 45.23)3 (2)----52 (30)5.76(0.70, 47.28)0.2223    Light88 (65)44 (32)7.25(0.88, 60.03)4 (3)----48 (35)7.86(0.95, 64.70)Reaction to First Sun of Season    No change11 (79)2 (14)1.00(Ref.)1 (7)1.00(Ref.)3 (21)1.00(Ref.)    Tan w/o burn35 (65)18 (33)2.38(0.38, 14.70)1 (2)0.36(0.01, 9.85)19 (35)1.69(0.34, 8.27)0.0644    Mild burn to tan101 (74)34 (25)1.45(0.28, 7.60)1 (1)----35 (26)0.93(0.22, 3.91)    Burn w/o blisters65 (69)26 (28)2.36(0.43, 13.06)3 (3)0.32(0.02, 4.85)29 (31)1.58(0.37, 6.81)    Blistering burn10 (42)13 (54)8.09(1.04, 62.71)1 (4)1.25(0.05, 28.98)14 (58)5.31(0.88, 31.89)Hours in mid-day sun (last 10 years)    \<7 h/week82 (72)30 (26)1.00(Ref.)2 (2)1.00(Ref.)32 (28)1.00(Ref.)    \<14 h/week57 (63)31 (34)1.60(0.84, 3.02)3 (3)2.70(0.41, 17.94)34 (37)1.66(0.90, 3.09)0.6797    \<28 h/week61 (73)21 (25)0.88(0.43, 1.79)1 (1)1.09(0.09, 12.85)22 (27)0.89(0.44, 1.78)    28+ h/week22 (63)12 (34)1.62(0.61, 4.30)1 (3)0.98(0.05, 19.91)13 (37)1.55(0.61, 3.99)*IRF4*GGCGCCCG/CCChi square(rs12211228)*n* (%)*n* (%)OR (95% CI)\**n* (%)OR (95% CI)\**p*OR (95% CI)\**p*Eye color    Dark brown44 (80)10 (18)1.00(Ref.)1 (2)1.00(Ref.)11 (20)1.00(Ref.)    Light brown15 (65)8 (35)2.13(0.64, 7.04)0 (0)----8 (35)1.82(0.56, 5.88)0.7095    Hazel51 (74)17 (25)1.46(0.58, 3.70)1 (1)0.40(0.02, 7.52)18 (26)1.34(0.55, 3.29)    Blue96 (70)38 (28)1.64(0.73, 3.69)4 (3)1.68(0.18, 15.72)42 (30)1.65(0.76, 3.58)    Green/blue-green29 (69)13 (31)1.83(0.64, 5.27)0 (0)----13 (31)1.54(0.55, 4.31)Hair color    Black/dark brown137 (69)55 (28)1.00(Ref.)6 (3)1.00(Ref.)61 (31)1.00(Ref.)    Medium brown102 (63)58 (36)1.38(0.87, 2.18)2 (1)0.48(0.09, 2.46)60 (37)1.29(0.82, 2.02)0.4696    Light brown/dark blonde124 (69)54 (30)1.15(0.73, 1.82)3 (2)0.62(0.15, 2.56)57 (31)1.10(0.70, 1.72)    Light blonde50 (68)23 (32)1.12(0.62, 2.05)0 (0)----23 (32)1.03(0.57, 1.87)    Red23 (77)6 (20)0.59(0.22, 1.59)1 (3)1.01(0.11, 9.48)7 (23)0.63(0.25, 1.61)Skin complexion    Dark14 (93)1 (7)1.00(Ref.)0 (0)----1 (7)1.00(Ref.)    Medium124 (71)46 (26)5.39(0.67, 43.48)4 (2)----50 (29)5.74(0.71, 46.25)0.4045    Light97 (73)39 (28)4.19(0.48, 36.91)2 (1)----41 (30)4.86(0.56, 42.31)Reaction to first sun of season    No change12 (86)2 (14)1.00(Ref.)0 (0)----2 (14)1.00(Ref.)    Tan w/o burn41 (76)12 (22)1.48(0.23, 9.73)1 (2)----13 (24)1.48(0.23, 9.73)0.7176    Mild burn to tan102 (74)33 (24)1.83(0.36, 9.31)2 (1)----35 (26)1.96(0.39, 9.90)    Burn w/o blisters64 (67)30 (32)2.67(0.52, 13.79)1 (1)----31 (33)2.72(0.53, 14.05)    Blistering burn15 (63)9 (38)4.61(0.57, 37.05)0 (0)----9 (38)4.61(0.57, 37.05)Hours in mid-day sun (last 10 years)    \<7 h/week78 (68)34 (30)1.00(Ref.)2 (2)1.00(Ref.)36 (32)1.00(Ref.)    \<14 h/week71 (77)19 (21)0.63(0.33, 1.22)2 (2)1.28(0.17, 9.67)21 (23)0.66(0.35, 1.26)0.8289    \<28h/week59 (70)24 (29)1.16(0.58, 2.29)1 (1)0.57(0.04, 7.83)25 (30)1.11(0.57, 2.18)    28+ h/week25 (71)9 (26)0.99(0.37, 2.68)1 (3)1.11(0.05, 25.05)10 (29)1.00(0.38, 2.63)Confidence interval *CI*, international unit *IU*, odds ratio *OR*, single nucleotide polymorphism *SNP*\* Adjusted for age, sex, study site

The *IRF4* rs12211228 SNP that was associated with NHL was not statistically significantly associated with any of the measures of sun sensitivity or sun exposure in this study (Table [4](#Tab4){ref-type="table"}). All results were consistent in analyses expanded beyond non-Hispanic Caucasians and adjusted for race/ethnicity.

The remaining *IRF4* SNPs evaluated were not found to be statistically significantly associated with measures of sun sensitivity (data not shown).

*Joint effects of IRF4 and sun sensitivity in NHL risk*. Table [5](#Tab5){ref-type="table"} shows the joint effects between eye and hair color and NHL risk for the two *a prioriIRF4* SNP genotypes. We observed no statistically significant *p*-interactions for either the *IRF4* rs12203592 or rs12211228 SNP with hair color or eye color. However, the risk estimates for NHL among individuals with lighter eye and hair color appeared more pronounced in those with either variant *IRF4* allele than in those with the corresponding common homozygote genotype. This is also observed in stratified analysis (Supplementary Table 2) whereby associations with NHL for eye and hair color appear more pronounced among those with a variant *IRF4* SNP. No joint effects with hair or eye color were observed for the remaining thirteen *IRF4* SNPs evaluated (data not shown).Table 5Joint effects of eye color and hair color (excluding red hair) and overall non-Hodgkin lymphoma risk with *IRF4* genotype, among non-Hispanic Caucasians*IRF4* SNPExposureGenotypeControlsAll NHLOR (95% CI)\**p*-value*p*-interaction*n* (%)*n* (%)rs12203592Eye color0.5475    Dark brownCC49 (15)79 (20)1.00(Ref.)CT/TT6 (2)17 (4)1.66(0.60, 4.55)0.3259    Light brownCC16 (5)20 (5)0.80(0.37, 1.71)0.5589CT/TT7 (2)10 (3)0.83(0.29, 2.37)0.7312    HazelCC41 (13)49 (12)0.74(0.43, 1.29)0.2944CT/TT27 (8)20 (5)0.44(0.22, 0.88)0.0204    BlueCC89 (27)99 (25)0.69(0.44, 1.11)0.1241CT/TT47 (14)54 (14)0.71(0.41, 1.22)0.2118    Green/blue-greenCC29 (9)30 (8)0.58(0.31, 1.11)0.0991CT/TT14 (4)16 (4)0.67(0.30, 1.52)0.3356Hair color0.6251    Black/dark brownCC112 (18)160 (21)1.00(Ref.)CT/TT85 (14)112 (14)0.92(0.63, 1.34)0.6706    Medium brownCC107 (17)166 (21)1.09(0.77, 1.54)0.6402CT/TT54 (9)72 (9)0.94(0.61, 1.45)0.7721    Light brown/dark blondeCC141 (23)174 (22)0.85(0.61, 1.18)0.3330CT/TT40 (7)32 (4)0.55(0.32, 0.94)0.0282    Light blondeCC62 (10)58 (7)0.65(0.42, 1.01)0.0546CT/TT11 (2)6 (1)0.36(0.13, 1.00)0.0496rs12211228Eye color0.5878    Dark brownGG44 (13)67 (17)1.00(Ref.)CG/CC11 (3)29 (7)1.69(0.76, 3.77)0.2011    Light brownGG15 (5)23 (6)1.04(0.48, 2.25)0.9121CG/GG8 (2)7 (2)0.54(0.18, 1.63)0.2710    HazelGG51 (16)49 (12)0.62(0.36, 1.09)0.0946CG/GG18 (6)20 (5)0.73(0.34, 1.55)0.4098    BlueGG96 (29)105 (27)0.73(0.45, 1.18)0.1951CG/GG42 (13)48 (12)0.76(0.43, 1.35)0.3501    Green/blue-greenGG29 (9)34 (9)0.71(0.38, 1.35)0.3008CG/GG13 (4)13 (3)0.64(0.27, 1.52)0.3096Hair color0.3200    Black/dark brownGG137 (22)187 (24)1.00(Ref.)CG/GG61 (10)86 (11)1.03(0.69, 1.54)0.8772    Medium BrownGG102 (17)176 (23)1.27(0.91, 1.78)0.1550CG/GG60 (10)63 (8)0.76(0.50, 1.16)0.2007    Light brown/dark blondeGG124 (20)146 (19)0.85(0.61, 1.18)0.3219CG/GG57 (9)60 (8)0.76(0.49, 1.17)0.2066    Light blondeGG50 (8)46 (6)0.65(0.41, 1.04)0.0727CG/GG23 (4)18 (2)0.58(0.30, 1.13)0.1094*CI* Confidence interval, *NHL* non-Hodgkin lymphoma, *OR* odds ratio, *SNP* single nucleotide polymorphism\* Adjusted for age, sex, and study center

Discussion {#Sec9}
==========

The independent associations observed in our data are consistent with those previously published for sun sensitivity and NHL \[[@CR19]\], for *IRF4* rs12203592 and hair color \[[@CR17]\], and for *IRF4* rs12211228 and NHL \[[@CR8]\], to which our data contributed. Of note, the *IRF4* rs12203592 SNP associated with hair color was not associated with NHL, and the *IRF4* rs12211228 SNP associated with NHL was not associated with hair color. The two *IRF4* SNPs are neither correlated nor in linkage disequilibrium with one another (*r*^2^=0.001, D'=0.04), and accordingly we found no statistically significant *p*-interactions between *IRF4* SNPs, measures of sun sensitivity such as hair color, and NHL risk. We do note that although associations between hair color and NHL risk were observed among those with and without variant *IRF4* rs12203592 or rs12211228 alleles, the risk estimates were slightly more pronounced among those with either variant *IRF4* genotype. We, therefore, cannot discount a possible interrelationship between the *IRF4* SNPs with sun sensitivity and NHL risk given our relatively small sample size to evaluate joint effects. We believe that further evaluation, such as in consortial settings where adequate sample sizes are available to assess joint effects, are needed to determine whether these two pathways both function through immune mediation or separately with one through immune mediation and one through pigmentation.

The major strengths of this study include the use of population-based selection for both cases and controls and the ascertainment of data on a range of measures designed to assess sun sensitivity and sun exposure in study subjects. Also, our study population reflects all three previously reported independent associations at the basis of this analysis, making it ideal for investigating potential joint effects. Study limitations include lower sample sizes available for some primary and secondary analyses resulting from the split-sample design, which allowed for the collection of sun exposure and sun sensitivity data in only half of the participant pool. This decreased the study's power to detect significant interactions. Additionally, the relatively low participation and response rates for the study increase the potential for selection bias in the sample.

We acknowledge that our data may not have detected a joint effect because none existed, because of limited sample size and power to detect a joint effect, or because of our imperfect measures for both genotype and sun exposures, which may have biased our results toward the null. The *IRF4* SNPs associated with NHL and hair color were originally identified as part of a tagging algorithm and thus are considered markers of susceptibility. The SNPs evaluated are thus surrogates and likely in linkage disequilibrium with the causal SNP. In addition, the specific mechanism by which sun sensitivity and sun exposure affects NHL risk is unknown and the pigmentation phenotypes such as hair color are considered surrogates for this measure. We, therefore, cannot exclude the possibility that our null observations for joint effects between *IRF4* and sun sensitivity are due to our having a poor surrogate marker for the causal factor(s). Finally, we also cannot exclude the possibility that joint effects may exist for specific NHL subtypes which we were unable to evaluate due to small numbers in our study.

In summary, our data support that genetic polymorphisms in the immune regulatory gene *IRF4* are linked to both risk for non-Hodgkin lymphoma and to hair color and other phenotypic measures of sun sensitivity and exposure. Further evaluation of joint effects in independent and larger populations is needed. If joint effects are shown, further investigations to identify the mechanisms by which sun sensitivity or exposure and *IRF4* genes function to modulate risk for NHL are warranted.
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CAPI

:   Computer-assisted personal interview

CI

:   Confidence interval

CLL/SLL

:   Chronic lymphocytic leukemia/small lymphocytic lymphoma

DLBCL

:   Diffuse large B-cell lymphoma

HHHQ

:   Health habits and history questionnaire

HWE

:   Hardy--Weinberg equilibrium

ICD-O

:   International classification of diseases for oncology

MAF

:   Minor allele frequency

NA

:   Not applicable

NCI

:   National cancer institute

NHANES

:   National health and nutrition examination survey

NHL

:   Non-Hodgkin lymphoma

OR

:   Odds ratio

SEER

:   Surveillance, epidemiology, and end results

SNP

:   Single nucleotide polymorphism

WT

:   Wild-type
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